In this edition of Where The Money Is, we discuss new Obamacare data, GlaxoSmithKline’s China fine, and new rules to combat tax inversions.

In this edition of Where The Money Is, we discuss new Obamacare data, GlaxoSmithKline’s China fine, and new rules to combat tax inversions.

&nbsp;
In this edition of Where The Money Is, we discuss new Obamacare data, GlaxoSmithKline’s China fine, and new rules to combat tax inversions.

Where the Money Is 09.24.2014

Healthcare, technology, energy, consumer goods, and more. Every day, Motley Fool analysts break down a specific industry and the stocks making headlines. Questions? Comments? Email us at IndustryFocus@fool.com.

Share Where the Money Is 09.24.2014

Sign up to save your podcasts

Where the Money Is 09.24.2014

Where the Money Is 09.24.2014